Biotechnology Company
To find out if this company and others are accepting funding, Sign up as Investor.
Cubed Biotech is a Montréal-based Canadian psychedelic biotechnology firm federally licensed from Health Canada to develop, manufacture, and commercialize psychedelic medicine in order to unnerve the current treatments of mental illness & addiction. Cubed cultivates, extracts, and purifies natural entheogens (i.e., psilocybin from mushrooms, mescaline from cacti, and ayahuasca’s DMT and monoamine oxidase inhibitors) with synthetic options. Our 19,000 square feet Montreal facility is the preeminent psychedelic factory in the world as told to us by a Nasdaq CEO. We are the only company in the world who produce 3 types of psilocybin: Natural Isolated, Full Tryptamine and Synthetic. Cubed’s drug development is focused on reverse engineering natural medicines with safe historical usage to produce finished drug products for Cubed and pharmaceutical companies.
Sign up or log in now to unlock profile details and access financials, company documents, and invest in companies.
We uniquely make natural isolated, strain-specific Full Tryptamine, and Synthetic Psilocybin.
CEO, DIRECTOR, FOUNDER • Marketed & branded 5 companies w/ annual sales over $10 million. • Disruptive products developed in Regulated Raw Dairy, CPG & Cannabis industries.• Over $150 million legal cannabis sales• Vice Chairman & Board Member of PsyCan, Canada's biotech trade association.
PRESIDENT, DIRECTOR , CO-FOUNDER• Instrumental in key financing rounds and scaling 4 psychedelic RTO’s.• Former Director and VP of multiple public companies. • Top 30 under 30 Award, 2016 E&Y Entrepreneur of the Year Nominee.
Montreal, QC H9B 3J1, Canada
Users who follow these tips increase their fundraising odds substantially.
No commitment. Start in minutes.
Already a member? Log In